Login / Signup

Risk of SARS-CoV2-related mortality in non-small cell lung cancer patients treated with first-line immunotherapy alone or in combination with chemotherapy.

Giuseppe Luigi BannaOrnella CantaleAlex FriedlaenderHarliana YusofShyamika AcharigeAlfredo Addeo
Published in: Cancer investigation (2021)
The addition of ChT to immunotherapy could be associated with increased risk of mortality and higher SARS-CoV-2-related mortality rate.
Keyphrases
  • sars cov
  • cardiovascular events
  • risk factors
  • respiratory syndrome coronavirus
  • type diabetes
  • cardiovascular disease
  • radiation therapy
  • locally advanced